Recently, the HLA class I and class II ligandome was characterized using immunoprecipitation and mass spectrometry in CD34+ stem/progenitor cells from AML and CML patients and CD34+CD38- healthy controls (66, 67). Here, CD34 is linked to acute myeloid leukemia.